Company Search:
Advanced Search
Sponsored Links
Pelion SA Company Snapshot
Pelion SA operates in the Drugs, proprietaries, and sundries sector. In addition to historical fundamental analyses, the complete report available to purchase compares Pelion SA with three other drug stores in Europe: Selcuk Ecza Deposu Ticaret ve Sanayi AS of Turkey (2016 sales of 8.64 billion Turkish Liras [US$2.46 billion] of which 100% was Medical and Hospital Equipment), Oriola Oyj of Finland (1.64 billion Euro [US$1.84 billion] of which 157% was Services), and Neuca SA (7.08 billion Polish New Zlotys [US$1.88 billion] of which 99% was Pharmaceutical Wholesale).

Sales Analysis. Pelion SA reported sales of 9.18 billion Polish New Zlotys (US$2.43 billion) for the year ending December of 2016. This represents an increase of 8.5% versus 2015, when the company's sales were 8.46 billion Polish New Zlotys. Sales at Pelion SA have increased during each of the previous five years (and since 2011, sales have increased a total of 40%). Sales of Other saw an increase of 11.0% in 2016, from 51.99 million Polish New Zlotys to 57.72 million Polish New Zlotys.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Pelion SA
  Stock Performance Chart for Pelion SA
  Stock Data: Recent Stock Performance:
  Current Price (6/7/2017): 58.80
(Figures in Polish New Zlotys)
1 Week n/a   13 Weeks n/a  
4 Weeks n/a   52 Weeks n/a  
Pelion SA Key Data:
  Ticker: PEL Country: Poland
  Exchanges: OTH WAR Major Industry: Health Care Equipment & Services
    Sub Industry: Drugs, Proprietaries, & Sundries
  2016 Sales 9,177,981,000
(Year Ending Jan 2017).
Employees: 9,363
  Currency: Polish New Zlotys Market Cap: 655,367,983
  Fiscal Yr Ends: December Shares Outstanding: 11,145,714
  Share Type: Akcje Closely Held Shares: 950,000
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.